This is a Validated Antibody Database (VAD) review about human PROCR, based on 5 published articles (read how Labome selects the articles), using PROCR antibody in all methods. It is aimed to help Labome visitors find the most suited PROCR antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
PROCR synonym: CCCA; CCD41; EPCR; endothelial protein C receptor; APC receptor; CD201 antigen; activated protein C receptor; cell cycle, centrosome-associated protein; centrocyclin; protein C receptor, endothelial
Abcam
rat monoclonal (RCR-252) |
| Abcam PROCR antibody (Abcam, Ab81712) was used in blocking or activating experiments on human samples at 10 ug/ml. J Biol Chem (2017) ncbi |
Sigma-Aldrich
rat monoclonal (RCR-252) |
| In order to research the virulence evolution of malaria parasite Plasmodium falciparum, Sigma-Aldrich PROCR antibody (Sigma-Aldrich, RCR-252) was used in flow cytometry on hamsters samples at 50 ug/ml (fig s2a). mSphere (2017) ncbi |
BD Biosciences
rat monoclonal (RCR-252) |
| In order to find cell-surface markers specific to human neutrophils, BD Biosciences PROCR antibody (BD, 557950) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi |
rat monoclonal (RCR-252) |
| In order to find that breast cancer stem cells isolated with CD44(+)CD24(-/lo)SSEA-3(+) or ESA(hi)PROCR(hi)SSEA-3(+) markers have higher tumorigenicity than those with conventional markers, BD Biosciences PROCR antibody (BD Biosciences, RCR-252) was used in flow cytometry on human samples (fig 2b). Proc Natl Acad Sci U S A (2016) ncbi |
rat monoclonal (RCR-252) |
| BD Biosciences PROCR antibody (BD Biosciences, 557950) was used in immunocytochemistry on dog samples . Methods Mol Biol (2013) ncbi |
Articles Reviewed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments